Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1267969615
rs1267969615
ACE
0.060 GeneticVariation BEFREE This study was designed to evaluate the angiotensin-converting enzyme insertion/deletion (ACE-I/D), angiotensinogen (AGT) M235T, and angiotensin II receptor type 1 (ATR1) A1166C and type 2 (ATR2) C3123A gene polymorphisms as risk factors for progression to ESRD in patients with VUR.Methods. 19288324

2009
dbSNP: rs1267969615
rs1267969615
ACE
0.060 GeneticVariation BEFREE We studied retrospectively the role of angiotensinogen (AGT) M235T, angiotensin converting enzyme (ACE) insertion/deletion (I/D), angiotensin II type 1 receptor (AT1R) A1166C, aldosterone syntase (CYP11B2) -344C/T and intron 2 W/C polymorphisms in conjunction with clinical and biochemical covariables on the rate of progression of renal insufficiency in a group of patients with ESRD of various etiologies. 12832734

2003
dbSNP: rs1267969615
rs1267969615
ACE
0.060 GeneticVariation BEFREE Two hundred and forty-six end-stage renal disease (ESRD) patients on peritoneal dialysis and 183 control subjects, all of Chinese origin, were genotyped for the ACE insertion/deletion (I/D) and the AGT M235T gene polymorphisms. 12675870

2003
dbSNP: rs1267969615
rs1267969615
ACE
0.060 GeneticVariation BEFREE There was no association between age at onset of ESRD and either M235T or A1166C polymorphism. 11136175

2001
dbSNP: rs1267969615
rs1267969615
ACE
0.060 GeneticVariation BEFREE Angiotensin I-converting enzyme gene insertion/deletion and angiotensinogen M235T polymorphisms: risk of chronic renal failure. End-Stage Renal Disease Study Group. 10916074

2000
dbSNP: rs1267969615
rs1267969615
ACE
0.060 GeneticVariation BEFREE There was no interaction between age of onset of ESRF and either the angiotensinogen M235T allele or angiotensin 1 receptor A1166C polymorphism. 9291178

1997